EP3452462A4 - SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF - Google Patents
SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF Download PDFInfo
- Publication number
- EP3452462A4 EP3452462A4 EP17792622.7A EP17792622A EP3452462A4 EP 3452462 A4 EP3452462 A4 EP 3452462A4 EP 17792622 A EP17792622 A EP 17792622A EP 3452462 A4 EP3452462 A4 EP 3452462A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- benzimidazol
- ethoxyethyl
- piperidinyl
- phenyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641015655 | 2016-05-05 | ||
| PCT/IN2017/000099 WO2017191651A1 (en) | 2016-05-05 | 2017-05-02 | Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3452462A1 EP3452462A1 (en) | 2019-03-13 |
| EP3452462A4 true EP3452462A4 (en) | 2019-10-23 |
Family
ID=60202837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17792622.7A Withdrawn EP3452462A4 (en) | 2016-05-05 | 2017-05-02 | SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3452462A4 (en) |
| WO (1) | WO2017191651A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021005403A2 (en) * | 2018-09-25 | 2021-06-15 | Glenmark Life Sciences Limited | processes for preparing bilastine crystalline form 2 and for preparing bilastine p-xylene solvate, and bilastine p-xylene solvate |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447682A (en) * | 2013-09-12 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | Bilastine compound |
| EP3327012A1 (en) * | 2015-07-24 | 2018-05-30 | Disproquima, S.A. | Crystalline forms of bilastine and preparation methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2124167B1 (en) * | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | NEW DERIVATIVES OF BENZMIDAZOLE WITH ANTIHISTAMINE ACTIVITY. |
| SI1505066T1 (en) * | 2002-04-19 | 2007-04-30 | Faes Farma Sa | Polymorph of acid 4-(2-(4-(1-(2-ethoxyethyl)-1h-benzimidazole-2-il)-1-piperidinyl)ethyl)-alpha, alpha-dimethyl-benzeneacetic |
| KR101123903B1 (en) * | 2008-02-12 | 2012-03-23 | 주식회사유한양행 | Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds |
| CZ307500B6 (en) * | 2012-08-15 | 2018-10-24 | Zentiva, K.S. | A method of the preparation of a 2-methyl-2'-phenylpropionic acid derivative employing novel intermediates |
-
2017
- 2017-05-02 WO PCT/IN2017/000099 patent/WO2017191651A1/en not_active Ceased
- 2017-05-02 EP EP17792622.7A patent/EP3452462A4/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447682A (en) * | 2013-09-12 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | Bilastine compound |
| EP3327012A1 (en) * | 2015-07-24 | 2018-05-30 | Disproquima, S.A. | Crystalline forms of bilastine and preparation methods thereof |
Non-Patent Citations (2)
| Title |
|---|
| "SYNTHESIS AND CRYSTALLINE FORMS OF BILASTINE", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 23 September 2016 (2016-09-23), XP013172874, ISSN: 1533-0001 * |
| See also references of WO2017191651A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3452462A1 (en) | 2019-03-13 |
| WO2017191651A1 (en) | 2017-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4467143C0 (en) | METHOD FOR THE PREPARATION OF 4-(4-(4-(((2-(2,6-DIOXOPIPERIDINE-3-YL)-L-OXOISOINDOLINE-4-YL)OXY)METHYL)BENZYL)PIPERAZINE-L-YL)-3-FLUOROBENZONITRILE | |
| EP3826467A4 (en) | PLATFORM FOR THE DEVELOPMENT OF SOIL-BORN PLANT PATHOGENS THAT INHIBIT MICROBIAL CONSORTIA | |
| EP4025214A4 (en) | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | |
| EP3746564A4 (en) | NUCLEIC ACID AMPLIFICATION PROCESS | |
| EP3344274A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASE CONDITIONS ASSOCIATED WITH ABNORMAL INFLAMMATORY RESPONSES | |
| EP3353309A4 (en) | COMPOSITIONS AND METHODS FOR GENOMIC EDITION | |
| IL256237A (en) | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidine-5-ylidin)methyl)furan-2-yl)benzoic acid | |
| EP3561059A4 (en) | COMPOSITION FOR EDITING BASES FOR AN ANIMAL EMBRYO AND METHOD FOR EDITING BASES | |
| EP3910062A4 (en) | MUTANT STRAIN OF PICHIA PASTORIS FOR THE EXPRESSION OF AN EXOGENOUS GENE | |
| EP2831284A4 (en) | COMPOSITIONS AND METHODS FOR COLLECTING AND ISOLATING NUCLEIC ACIDS FROM BIOLOGICAL SPECIMENS | |
| DK3644999T3 (en) | COMPOSITIONS AND METHODS OF USING 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUORACETAMIDE | |
| EP2578574A4 (en) | OPTICALLY ACTIVE DIBENZYLAMINE DERIVATIVE AND PROCESS FOR PREPARING THE SAME | |
| DK2987791T3 (en) | 3- (4- (Benzyloxy) phenyl) hex-4-acid acid derivative, suitable for the prevention and treatment of metabolic disorders | |
| EP3529232A4 (en) | SULFAMIC ACID DERIVATIVES AND METHODS FOR THEIR PREPARATION | |
| MA46791A (en) | COMPOUNDS AND METHODS FOR REDUCING THE EXPRESSION OF ATXN3 | |
| EP3411383A4 (en) | METHODS FOR EXTRACTING PROTEINS FROM BLOOD MATERIAL | |
| EP3469078A4 (en) | METHODS AND COMPOSITIONS FOR AMPLIFICATION OF NUCLEIC ACID | |
| DK3227273T3 (en) | COMPOSITIONS INCLUDING 2 - ((1- (2 (4-FLUOROPHENYL) -2-OXOETHYL) PIPERIDIN-4-YL) METHYL) ISOINDOLIN-1-ON, FOR THE TREATMENT OF SKIZOFRENIA | |
| EP3402883A4 (en) | COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING | |
| EP3848115A4 (en) | LACTIC ACID ABSORBER AND METHOD FOR REMOVAL OF LACTIC ACID | |
| DK2763981T3 (en) | PROCEDURE FOR THE PREPARATION OF 1- (4- (4- (3,4-DICHLOR-2-FLUORPHENYLAMINO) -7-METHOXYQUINAZOLIN-6-YLOXY) PIPERIDIN-1-YL) -PROP-2-EN-1-ON HYDROCHLORIDE AND INTERMEDIATES USED THEREOF | |
| EP3368010A4 (en) | SOLID GALENIC FORM WITH IMMEDIATE RELEASE OF MEDICINE AND APPARATUS AND METHOD FOR MANUFACTURING THE SAME | |
| EP3859332A4 (en) | GLYQUATED HEMOGLOBIN (%) ASSAY METHOD | |
| PL3976589T3 (en) | Methods for the preparation of 5-bromo-2-(3-chloropyridin-2-yl)-2H-pyrazole-3-carboxylic acid | |
| EP3486030A4 (en) | MACHINING JIG AND METHOD OF MACHINING |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20181205 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20190919 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 235/14 20060101ALI20190914BHEP Ipc: C07D 235/08 20060101ALI20190914BHEP Ipc: C07D 211/62 20060101ALI20190914BHEP Ipc: C07D 401/04 20060101AFI20190914BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20200702 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20210727 |